Leili Gao

9PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsClinical nutritionTraditional Chinese medicine and treatmentsMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 22, 2025
Efficacy and safety of chiglitazar add-on to metformin in type 2 diabetes mellitus (RECAM study).

Leili Gao, Linong Ji, Xin Yan

|Oct 22, 2024
Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, phase 3 trial.

Leili Gao, Fang Bian, Tianrong Pan

|Sep 19, 2023
A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy.

Linong Ji, Jinmiao Lu, Leili Gao

|Sep 04, 2023
Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial.

Linong Ji, Jinmiao Lu, Leili Gao

|Jun 13, 2023
The effects of daily dose and treatment duration of metformin on the prevalence of vitamin B12 deficiency and peripheral neuropathy in Chinese patients with type 2 diabetes mellitus: A multicenter cross-sectional study.

Leili Gao, Xingwu Ran, Xuejun Liu

|Nov 26, 2022
Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial.

Leili Gao, Zhifeng Cheng, Benli Su

Pageof 2

Frequent Collaborators

5 joint publications

Linong Ji

3 joint publications

Linong Ji

2 joint publications

Jinmiao Lu

1 joint publications

Jianping Weng